Actavis PLC (NYSE:ACT)

301.22
Delayed Data
As of May 21
 +3.72 / +1.25%
Today’s Change
201.91
Today|||52-Week Range
317.72
+17.02%
Year-to-Date

Today’s Trading

Previous close297.50
Today’s open298.16
Day’s range-- - --
Volume2,214,844
Average volume (3 months)3,192,635
Market cap$116.8B
Dividend yield--
Data as of 05/21/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+27.70%
Earnings growth (next 5 years)+13.50%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book2.79

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.19-0.28%
NVONovo Nordisk+0.51+0.89%
GSKGlaxoSmithKline+0.68+1.52%
ABBVAbbVie-0.24-0.36%
Data as of 05/21/2015

Financials

Last reporting dateMay 11, 2015
EPS forecast (this quarter)$4.26
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers